BioSpace News Archive

Avacta Group plc, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that it has entered into a non-exclusive distribution agreement with Calibre Scientific Inc., a global provider of life science products, for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test for professional use in the UK and European Economic Area.

Allogene Overland Biopharm, a joint venture created by Overland Pharmaceuticals and Allogene Therapeutics, Inc., announced the appointment of Shuyuan Yao, Ph.D. as Chief Executive Officer.

Houston area non-profit research organization Hope Biosciences Stem Cell Research Foundation has received Food and Drug Administration authorization for a Phase II clinical trial to assess the efficacy and safety of multiple intravenous infusions of allogeneic adipose-derived mesenchymal stem cells in improving activities of daily living and quality of life in subjects with Parkinson’s Disease.

Arrowhead Pharmaceuticals Inc. and Horizon Therapeutics plc announced a global collaboration and license agreement for ARO-XDH, a previously undisclosed discovery-stage investigational RNA interference therapeutic being developed by Arrowhead as a potential treatment for people with uncontrolled gout.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced presentation of the positive Phase 2 safety and efficacy data for oral opaganib [1] in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum 2021.

Diffusion Pharmaceuticals Inc. today announced that CEO Robert Cobuzzi, Jr., Ph.D., will present via webcast at the Life Sciences Investor Forum being held on June 24, 2021.

GenScript Biotech Corporation announced today that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralization Technology.

GlaxoSmithKline plc and Vir Biotechnology, Inc. announced final, confirmatory results from the Phase 3 COMET-ICE trial demonstrating that sotrovimab, an investigational SARS-CoV-2 monoclonal antibody, significantly reduced the risk of hospitalization or death among high-risk adult outpatients with mild-to-moderate COVID-19.

Arcadia (arcadia.io), the leading population health management and health intelligence platform, today announced that it has been cited by KLAS Research as one of today’s most well-rounded population health management (PHM) vendors,4 standing out in terms of customer experience, market energy, and breadth of PHM capabilities

Intercept Pharmaceuticals, Inc. announced that multiple abstracts regarding the treatment of primary biliary cholangitis and nonalcoholic steatohepatitis with obeticholic acid will be presented at the Digital International Liver Congress™ 2021, the 56th Annual Meeting of the European Association for the Study of the Liver, to be held virtually from June 23 to June 26, 2021.